REAL WORLD DRUG UTILIZATION OF HIV THERAPIES IN CANADA
Author(s)
Rocchi A1, Cui Q2, Ismaila A3, de los Rios P4
1Axia Research Inc., Burlington, ON, Canada, 2GlaxoSmithKline, Mississauga, ON, Canada, 3GlaxoSmithKline, Research Triangle Park, NC, USA, 4ViiV Healthcare, Laval, QC, Canada
OBJECTIVES: To describe current utilization of HIV drugs in Canada. METHODS: Longitudinal pharmacy retail data were obtained from most Canadian provinces. Eligible patients received their first HIV drug prescription during the selection period, and consistently filled subsequent prescriptions at the same pharmacy. Selection periods included an early cohort (initiating therapy January 2008 to July 2009) and a late cohort (initiating therapy August 2010 to February 2012). The observation period was 43 months for the early cohort and 12 months for the late cohort. RESULTS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PIN96
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior
Disease
Infectious Disease (non-vaccine)